G1 Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
VELLECA MARK A. director
 Common Stock 7,500 N/A N/A
Option
MALIK RAJESH officer: Chief Medical Officer
 Common Stock 3,776 N/A N/A
Option
VELLECA MARK A. director
 Common Stock 7,500 N/A N/A
Option
VELLECA MARK A. director
 Stock Options (Right to Buy) 7,500 N/A N/A
Option
MALIK RAJESH officer: Chief Medical Officer
 Stock Options (Right to Buy) 3,776 $2.28 $8,609
Option
MALIK RAJESH officer: Chief Medical Officer
 Stock Options (Right to Buy) 3,776 N/A N/A
Option
MALIK RAJESH officer: Chief Medical Officer
 Common Stock 3,776 $2.28 $8,609
Option
MALIK RAJESH officer: Chief Medical Officer
 Stock Options (Right to Buy) 4,200 N/A N/A
Option
MALIK RAJESH officer: Chief Medical Officer
 Common Stock 4,200 N/A N/A
Sale
MOSES JENNIFER K. officer: CFO
 Common Stock 750 N/A N/A
Option
MOSES JENNIFER K. officer: CFO
 Stock Options (Right to Buy) 750 N/A N/A
Option
MOSES JENNIFER K. officer: CFO
 Common Stock 750 N/A N/A
Sale
VELLECA MARK A. director
 Common Stock 7,500 N/A N/A
Option
VELLECA MARK A. director
 Stock Options (Right to Buy) 7,500 N/A N/A
Option
VELLECA MARK A. director
 Common Stock 7,500 N/A N/A
Option
MALIK RAJESH officer: Chief Medical Officer
 Stock Options (Right to Buy) 3,776 N/A N/A
Option
MALIK RAJESH officer: Chief Medical Officer
 Common Stock 3,776 N/A N/A
Option
MALIK RAJESH officer: Chief Medical Officer
 Stock Options (Right to Buy) 3,776 $0.35 $1,303
Sale
MALIK RAJESH officer: Chief Medical Officer
 Common Stock 3,776 N/A N/A
Option
MOSES JENNIFER K. officer: CFO
 Stock Options (Right to Buy) 750 N/A N/A
Sale
MOSES JENNIFER K. officer: CFO
 Common Stock 750 N/A N/A
Option
MOSES JENNIFER K. officer: CFO
 Common Stock 750 N/A N/A
Option
VELLECA MARK A. director
 Common Stock 7,500 N/A N/A
Sale
MALIK RAJESH officer: Chief Medical Officer
 Common Stock 3,776 N/A N/A
Option
VELLECA MARK A. director
 Stock Options (Right to Buy) 7,500 N/A N/A
Sale
VELLECA MARK A. director
 Common Stock 7,500 N/A N/A
Option
MALIK RAJESH officer: Chief Medical Officer
 Stock Options (Right to Buy) 3,776 N/A N/A
Option
MALIK RAJESH officer: Chief Medical Officer
 Common Stock 3,776 N/A N/A
Sale
MOSES JENNIFER K. officer: CFO
 Common Stock 750 N/A N/A
Option
MOSES JENNIFER K. officer: CFO
 Common Stock 750 N/A N/A
Option
MOSES JENNIFER K. officer: CFO
 Stock Options (Right to Buy) 750 N/A N/A
Sale
VELLECA MARK A. director
 Common Stock 7,500 N/A N/A
Option
VELLECA MARK A. director
 Common Stock 7,500 N/A N/A
Option
VELLECA MARK A. director
 Stock Options (Right to Buy) 7,500 N/A N/A
Sale
MEDIMMUNE VENTURES, INC. 10 percent owner
 Common Stock, $0.0001 par value per share 200,000 N/A N/A
Sale
MEDIMMUNE VENTURES, INC. 10 percent owner
 Common Stock, $0.0001 par value per share 133,906 N/A N/A
Sale
MEDIMMUNE VENTURES, INC. 10 percent owner
 Common Stock, $0.0001 par value per share 200,000 N/A N/A
Purchase
ESHELMAN FREDRIC N director
 Common Stock 250,000 N/A N/A
Purchase
ESHELMAN FREDRIC N director
 Common Stock 300,000 N/A N/A
Purchase
MUIR GLENN P director
 Common Stock 20,000 N/A N/A
Purchase
ESHELMAN VENTURES, LLC 10 percent owner
 Common Stock 300,000 N/A N/A
Purchase
THORP CLAY 10 percent owner
 Common Stock 133,333 N/A N/A
Purchase
MEDIMMUNE VENTURES, INC. 10 percent owner
 Common Stock 75,000 N/A N/A
Purchase
RA CAPITAL MANAGEMENT, LLC other: Fmr 10% Owner See Footno..
 Common Stock 400,000 N/A N/A
Purchase
MEDIMMUNE VENTURES, INC. 10 percent owner
 Common Stock, $0.0001 par value per share 75,000 N/A N/A

Showing 350 to 395 of 395 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: